Mallinckrodt, Endo filed US premerger form on April 11; Irish clearance required
MLex Summary: Drugmakers Mallinckrodt and Endo need to secure merger antitrust clearance for their $6.7 billion deal in the United States and Ireland. The companies submitted their US premerger forms on April...To view the full article, register now.
Already a subscriber? Click here to view full article